CWG
CLVS

C WorldWide Group’s Clovis Oncology, Inc. CLVS Stock Holding History

C WorldWide Group’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-63,530
Closed -$1.58M – 113
2019
Q1 		$1.58M Sell
63,530
-4,962
-7% -$124K 0.02% 100
2018
Q4 		$1.23M Sell
68,492
-22,664
-25% -$463K 0.02% 97
2018
Q3 		$2.68M Sell
91,156
-15,249
-14% -$590K 0.03% 86
2018
Q2 		$4.84M Sell
106,405
-29,943
-22% -$1.46M 0.07% 68
2018
Q1 		$7.2M Sell
136,348
-33,352
-20% -$1.95M 0.11% 49
2017
Q4 		$11.5M Sell
169,700
-40,927
-19% -$2.86M 0.17% 39
2017
Q3 		$17.4M Sell
210,627
-12,933
-6% -$1.03M 0.25% 32
2017
Q2 		$20.9M Sell
223,560
-85,609
-28% -$5.24M 0.32% 29
2017
Q1 		$19.7M Sell
309,169
-16,336
-5% -$993K 0.33% 29
2016
Q4 		$14.5M Buy
+325,505
New +$11.5M 0.28% 32

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

C WorldWide Group's CLVS Position: Q2 2019 in Review

C WorldWide Group sold out of Clovis Oncology, Inc. (CLVS) in Q2 2019, closing a stake of 63,530 shares — an estimated $1.58M sold.

C WorldWide Group first reported a position in CLVS in Q4 2016 and held it in 10 quarters. The position peaked at $20.9M in Q2 2017. 167 funds tracked by Wall St. Rank hold CLVS as of Q2 2019.

  • C WorldWide Group reported no remaining Clovis Oncology, Inc. position as of Q2 2019 after selling out during the quarter.
  • C WorldWide Group sold 63,530 Clovis Oncology, Inc. shares in Q2 2019, an estimated $1.58M.
  • C WorldWide Group first reported a position in Clovis Oncology, Inc. in Q4 2016 and held it in 10 quarters.
  • C WorldWide Group's Clovis Oncology, Inc. position peaked at $20.9M in Q2 2017.
  • 167 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2019.

Based on C WorldWide Group's 13F filing for Q2 2019, filed 2 Aug 2019.